ADVERTISEMENT

Custom Search
Today's Health Headlines
LOUISVILLE, Kentucky (Reuters) - Patricia Canon drives poor rural Kentucky women to distant abortion clinics each week, part of a national army of volunteers who are growing bolder even as abortion foes ratchet up opposition to the activists they have branded as "accomplices to murder."

LONDON, (Reuters) - HIV experts at an international conference starting on Saturday are keenly courting colleagues in oncology to explore whether advances in harnessing the immune system against cancer can help the search for a cure for AIDS.

NEW DELHI (Reuters) - The state government in India's capital told Philip Morris International Inc and other tobacco companies on Saturday to remove all advertisements from tobacco shops in the city, warning them of legal action if they do not comply.

(Reuters) - Republicans in the U.S. Senate were dealt another blow in their effort to repeal Obamacare on Friday when the keeper of the Senate's rules said certain provisions in their healthcare bill, such as defunding Planned Parenthood, could not be included.

NEW DELHI (Reuters) - India plans to seek an explanation from Philip Morris International Inc about its marketing practices after Reuters reported that the tobacco giant used tactics that government officials say flout the country's law, a health ministry official said on Friday.

(Reuters) - An outbreak of salmonella food poisoning linked to a type of papaya has sickened 47 people from 12 states, including one person in New York City who died and 12 who were hospitalized, U.S. health officials said on Friday.

LONDON (Reuters) - British pharmacy chain Boots has apologized for its response to a campaign calling for it to cut the price of one of its morning-after pills and said it was looking for cheaper alternatives.

FRANKFURT (Reuters) - Germany's Bayer said on Friday a cancer treatment for patients with a type of tumor often caused by asbestos had failed to meet its main goal in a clinical trial.

ZURICH (Reuters) - A European Medicines Agency (EMA) panel recommended on Friday approval of a new Novartis drug to be used against a tough-to-cure form of blood cancer as the Swiss drugmaker makes headway on refreshing its oncology portfolio.

(Reuters) - European regulators on Friday recommended against granting approval to a breast cancer drug being developed by Nektar Therapeutics and Daiichi Sankyo's German unit.

Welcome Guest
Username: 
Password:
Not a member? Sign Up!
Browse RSS Feeds
click here when finished
Save Page Layout
Video
loading